Believe in Progress
In the latest episode of Believe in Progress, Howard Brown, a two-time stage 4 cancer survivor, tech entrepreneur, author, and fierce advocate for research, provides updates about his latest cancer challenge.
Listen and Subscribe
In the latest episode of Believe in Progress, Howard Brown, a two-time stage 4 cancer survivor, tech entrepreneur, author, and fierce advocate for research, provides updates about his latest cancer challenge.
Listen and Subscribe
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreFour in 10 cancers diagnosed in the United States each year are related to potentially preventable causes. Read about cancer risk reduction in the AACR Cancer Progress Report.
Read the ReportMore than 80,000 people in the U.S. were diagnosed with non-Hodgkin lymphoma last year. Learn more about these cancers, including treatment options.
Learn MoreAACR President 2024-2025 Patricia M. LoRusso, DO, PhD (hc): Translating Personal Experience With Cancer Into the Search for New Cancer Therapeutics
Learn MoreFinancial Fallout: Nearly half of cancer survivors report their treatment left them in debt.
Read Practical KnowledgeYour donation to the American Association for Cancer Research will help fund early-career investigators. Fund the future of cancer research today.
Donate NowAdvance registration is open for the AACR Annual Meeting 2025. Register by Friday, March 7, to receive discounted rates.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
